|
PPAP2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62481139653892E-12 |
| Normal-vs-Stage2 |
1.17880039063323E-10 |
| Normal-vs-Stage3 |
1.20479999976553E-07 |
| Normal-vs-Stage4 |
6.73870004241905E-09 |
| Stage1-vs-Stage2 |
3.194200E-01 |
| Stage1-vs-Stage3 |
1.326800E-01 |
| Stage1-vs-Stage4 |
8.018600E-01 |
| Stage2-vs-Stage3 |
5.237000E-01 |
| Stage2-vs-Stage4 |
3.064200E-01 |
| Stage3-vs-Stage4 |
2.685000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.0875966793833E-11 |
| Normal-vs-Asian |
6.13059999999832E-05 |
| Caucasian-vs-AfricanAmerican |
1.052050E-01 |
| Caucasian-vs-Asian |
7.870000E-01 |
| AfricanAmerican-vs-Asian |
7.502000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
1.37919675680109E-11 |
| Male-vs-Female |
1.728010E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.53179999479769E-08 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
7.43882733189594E-12 |
| Normal-vs-Extreme_Obese |
2.18779999672236E-08 |
| Normal_Weight-vs-Extreme_Weight |
5.409500E-02 |
| Normal_Weight-vs-Obese |
5.953800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.845400E-01 |
| Extreme_Weight-vs-Obese |
3.948000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.335600E-01 |
| Obese-vs-Extreme_Obese |
5.362400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.30280000121274E-08 |
| Normal-vs-Age(41-60Yrs) |
6.33937347060964E-14 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
6.2532999889342E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.528400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.747600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.021000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.148200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.082400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.579200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.6242562850266E-12 |
| Normal-VS-Type2 PRCC |
2.30560015523906E-10 |
| Normal-VS-KIRP CIMP |
1.99820004986861E-09 |
| Normal-VS-Unclassified PRCC |
9.1496810128433E-12 |
| Type1 PRCC-VS-Type2 PRCC |
5.84670000000065E-05 |
| Type1 PRCC-VS-KIRP CIMP |
9.503400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.052100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.457400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.755410E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.593200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.80550069023889E-11 |
| Normal-vs-N1 |
2.30440000414944E-09 |
| Normal-vs-N2 |
1.781360E-04 |
| N0-vs-N1 |
6.740200E-01 |
| N0-vs-N2 |
7.836600E-01 |
| N1-vs-N2 |
9.339800E-01 |
|
|
